Low molecular weight inhibitors of complement proteases
US6683055B1 · kind B1 · utility
9Cited by
5References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2000 |
| Grant date | Jan 27, 2004 |
| Priority date | — |
| Expiry date | Mar 30, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptide substances, their preparation and their use as complement inhibitors are described. These are in particular substances having a guanidine or amidine radical as a terminal group. In particular, inhibitors of the complement proteases C1s and C1r are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.